Reduced motility of glioblastoma cells treated with ADAM10-targeted siRNA has been observed (Kohutek et al., 2009) and invasiveness of pituitary adenomas correlated with ADAM10 expression level (Pan et al., 2012). The gene discussed is ADAM10; the disease is pituitary gland adenoma.